Clinical Genomics Inc, based in Bridgewater, NJ, is a leading biotechnology company specializing in the development and commercialization of innovative diagnostic products for the detection and monitoring of colorectal cancer. With a strong leadership team and a rich history in the field, Clinical Genomics is at the forefront of advancing precision medicine in the fight against this prevalent disease.
Offering cutting-edge products such as COLVERA and InSure ONE, Clinical Genomics provides healthcare professionals and organizations with reliable and accurate tools for early detection and risk assessment. Through their commitment to clinical excellence and extensive research publications, Clinical Genomics continues to make significant contributions to the field of colorectal cancer diagnostics.
Generated from the website